Cardinal Health Inc (CAH)
Industry Medical Distribution
This stock can be held in an Investment ISA and an Investment Account
Sell
$126.38
Buy
$126.49
$-0.31 (-0.24%)
Cardinal Health Inc is a healthcare services company. It provides services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices.
Prices updated at 20 Feb 2025, 14:57 EST
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
129,976m | 136,809m | 145,534m | 152,922m | 162,467m | 181,326m | 204,979m | 226,827m | |
6,544m | 7,181m | 6,834m | 6,868m | 6,778m | 6,484m | 6,874m | 7,414m | |
2,242m | 1,878m | 1,733m | 1,772m | 1,794m | 1,648m | 1,789m | 2,130m | |
1.72 | 1.37 | 1.19 | 1.16 | 1.10 | 0.91 | 0.87 | 0.94 | |
1,288m | 256m | 1,363m | -3,696m | 611m | -938m | 330m | 852m | |
2,842m | 1,133m | 3,045m | -2,621m | 1,286m | 55m | 1,439m | 1,962m | |
Sales, General and administrative | 3,775m | 4,596m | 4,480m | 4,572m | 4,533m | 4,512m | 4,800m | 5,000m |
Interest expenses | 201m | 329m | 294m | 238m | 180m | 147m | 84m | 51m |
Provision for income taxes | 630m | -487m | 386m | -79m | -289m | 153m | 332m | 348m |
Operating expenses | 4,302m | 5,303m | 5,101m | 5,096m | 4,984m | 4,836m | 5,085m | 5,284m |
Income before taxes | 1,924m | -228m | 1,751m | -3,772m | 323m | -784m | 663m | 1,201m |
Net income available to common shareholders | 1,288m | 256m | 1,363m | -3,696m | 611m | -938m | 330m | 852m |
5.77 | 0.02 | -14.34 | 4.66 | 1.94 | -4.56 | 2.53 | 5.41 | |
Net interest income | -201m | -329m | -294m | -238m | -180m | -147m | -84m | -51m |
Advertising and promotion | - | - | - | - | - | - | - | - |
Net investment income, net | - | - | - | - | - | - | - | - |
Realised capital gains (losses), net | - | - | - | - | - | - | - | - |
Total benefits, claims and expenses | - | - | - | - | - | - | - | - |
Earnings per share (diluted) | 5.74 | 0.01 | -14.34 | 4.65 | 1.93 | -4.56 | 2.52 | 5.37 |
Free cash flow per share | 5.9781 | 5.0545 | 4.5628 | 8.5612 | 3.8362 | 12.3673 | 11.1532 | 4.3821 |
Book value/share | 21.2 | 19.8423 | 3.0822 | 4.8367 | 5.0289 | -6.8764 | -14.3386 | -13.5413 |
Debt equity ratio | 1.331962 | 1.32233 | 1.197693 | 3.781442 | 2.995533 | - | - | - |
Balance sheet
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current assets | 28,345m | 24,553m | 25,747m | 25,940m | 31,048m | 32,935m | 33,833m | 34,884m |
Current liabilities | 21,221m | 22,893m | 24,109m | 23,615m | 27,624m | 30,550m | 33,706m | 35,640m |
Total capital | 15,876m | 14,071m | 13,907m | 8,554m | 7,156m | 4,026m | 1,057m | 1,445m |
Total debt | 10,395m | 9,013m | 8,031m | 6,775m | 6,236m | 5,315m | 4,701m | 5,092m |
Total equity | 6,808m | 6,059m | 6,328m | 1,789m | 1,791m | -709m | -2,852m | -3,213m |
Total non current liabilities | - | - | - | - | - | - | - | - |
Loans | 9,068m | 8,012m | 7,579m | 6,765m | 5,365m | 4,735m | 3,909m | 4,658m |
Total assets | 40,112m | 39,951m | 40,963m | 40,766m | 44,453m | 43,878m | 43,417m | 45,121m |
Total liabilities | - | - | - | - | - | - | - | - |
Cash and cash equivalents | 6,879m | 1,763m | 2,531m | 2,771m | 3,407m | 4,717m | 4,043m | 5,133m |
Common stock | 316m | 309m | 299m | 293m | 291m | 273m | 251m | 244m |
Cash flow
Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2,356m | 6,879m | 1,763m | 2,531m | 2,771m | 3,407m | 4,717m | 4,076m |
Cash dividends paid | -577m | -581m | -577m | -569m | -573m | -559m | -525m | -499m |
797m | 2,384m | 2,394m | 1,585m | 2,029m | 2,735m | 2,358m | 3,251m | |
Investments (gains) losses | -405m | -5,608m | 338m | 493m | -378m | 567m | -454m | -1,849m |
6,879m | 1,763m | 2,531m | 2,771m | 3,407m | 4,717m | 4,043m | 5,133m | |
Net income | - | - | - | - | - | - | - | - |
1,184m | 2,768m | 2,722m | 1,960m | 2,429m | 3,122m | 2,839m | 3,762m | |
-387m | -384m | -328m | -375m | -400m | -387m | -481m | -511m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.